DC Field | Value | Language |
dc.contributor.author | Procopciuc, Vitalie | |
dc.contributor.author | Dumbraveanu, Lilia | |
dc.contributor.author | Lupan, Valentina | |
dc.date.accessioned | 2020-07-05T20:33:11Z | |
dc.date.available | 2020-07-05T20:33:11Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | PROCOPCIUC, Vitalie, DUMBRAVEANU, Lilia, LUPAN, Valentina. The use of amniotic membrane in the treatment of corneal ulcers and ocular surface defects. In: MedEspera: the 6th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2016, p. 187. | en_US |
dc.identifier.isbn | 978-9975-3028-3-8. | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/10923 | |
dc.description | Department of Ophthalmology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova,
The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016 | en_US |
dc.description.abstract | Introduction: The human amniotic membrane (HAM) has been proved to possess a vast variety
of beneficial effects (stimulation of epithelialization, antiangiogenic, antibacterial and antiinflamatory
effects), which can be very useful in many ophthalmological indications, such as corneal trophic ulcers
resistant to medication and some cases of ocular surface destruction.This paper is an attempt to introduce
the HAM transplantation indications in ophtalmology, to present the methods an techniques of HAM
aplication on the human eye, to describe our experience with the amniotic membrane and to analyse the
transplantation outcomes in patients with corneal ulcers of diverse etiology.
Materials and methods: A total of 19 patients were included in the study. All of them underwent
HAM transplantation at the MCH „St. Trinity”. The patients presented corneal ulcers of various
complexity and etiology and were distributed in 3 main categories: group A (n=14), which included
patients with corneal erosions in dry eye syndrome (n=5), viral keratitis (n=6), persistent epithelial
defects after corneal abscess (n=2) and chemical burns (n=1); group B (n=4), which included patients
with severe stromal thinning and iminent corneal perforation; group C (n=1), with one case of
symblepharon and extensive corneo-conjunctival adhesions. The HAM was prepared from a fresh
placenta of a seronegative pregnant woman and stored at -80°C. The amniotic membrane was applied
on the ocular surface using the „patch” technique.
Results: The cornea regeneratedsatisfactory in 11 patientsout of 14 in group A, but the epithelial
defect recurred in 3 of them. In the second group the transplantation was less effective - 2 patientsout of
4 needed further tectonic corneal graft and1 penetrant keratoplasty was performed. The HAM
transplantation showed good results in symblepharon surgery, facilitating epithelialization and
preventing corneo-conjunctival adhesions in the group C.
Conclusions: The HAM transplantation showed good results in facilitating corneal healing and
regeneration in patients with persistent epithelial defects, as well as preventing corneo-conjunctival
adhesions followingsymblepharon surgery. Nevertheless, in some cases,further surgerywas needed for
ocular surface reconstruction, as the HAM transplantation wasn’t effective enough to prevent the
tectonic corneal graft if severe stromal thinning and impending corneal perforation were involved. | en_US |
dc.language.iso | en | en_US |
dc.subject | human amniotic membrane | |
dc.subject | corneal ulcers | |
dc.subject.ddc | 61:378.661(478-25)(082) M 54 | en_US |
dc.title | The use of amniotic membrane in the treatment of corneal ulcers and ocular surface defects | en_US |
dc.type | Article | en_US |
Appears in Collections: | MedEspera 2016
|